 Zachary Clayton
Concepts (213)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Vascular Stiffness | 10 | 2024 | 463 | 2.900 |
Why?
| | Aging | 15 | 2024 | 1745 | 2.420 |
Why?
| | Cardiovascular Diseases | 9 | 2024 | 1994 | 1.770 |
Why?
| | Exercise | 8 | 2025 | 1917 | 1.710 |
Why?
| | Endothelium, Vascular | 8 | 2025 | 844 | 1.580 |
Why?
| | Diet | 7 | 2024 | 1198 | 1.570 |
Why?
| | Eggs | 5 | 2021 | 24 | 1.530 |
Why?
| | Inflammation | 12 | 2023 | 2646 | 1.370 |
Why?
| | Aorta | 6 | 2024 | 408 | 1.290 |
Why?
| | Arteries | 6 | 2024 | 261 | 1.250 |
Why?
| | Oxidative Stress | 5 | 2024 | 1181 | 1.220 |
Why?
| | Glucose Intolerance | 2 | 2021 | 142 | 1.180 |
Why?
| | Cellular Senescence | 3 | 2023 | 173 | 1.140 |
Why?
| | Insulin Resistance | 5 | 2024 | 1164 | 1.080 |
Why?
| | Mice, Inbred C57BL | 9 | 2024 | 5268 | 1.060 |
Why?
| | Elastin | 2 | 2023 | 77 | 1.010 |
Why?
| | Vasodilation | 3 | 2024 | 461 | 0.930 |
Why?
| | Work-Life Balance | 1 | 2024 | 17 | 0.920 |
Why?
| | Diet, Western | 2 | 2021 | 79 | 0.890 |
Why?
| | Spermidine | 1 | 2024 | 17 | 0.880 |
Why?
| | Flavonols | 1 | 2023 | 12 | 0.880 |
Why?
| | Vascular Diseases | 2 | 2023 | 232 | 0.870 |
Why?
| | Obesity | 7 | 2024 | 2859 | 0.850 |
Why?
| | Motor Activity | 4 | 2024 | 667 | 0.820 |
Why?
| | Polyketides | 1 | 2022 | 3 | 0.820 |
Why?
| | Angiotensin II | 1 | 2022 | 93 | 0.750 |
Why?
| | Blood Glucose | 4 | 2019 | 2092 | 0.750 |
Why?
| | Spirostans | 1 | 2021 | 4 | 0.740 |
Why?
| | Pulse Wave Analysis | 7 | 2023 | 246 | 0.720 |
Why?
| | Mice | 16 | 2024 | 16574 | 0.720 |
Why?
| | Atherosclerosis | 1 | 2025 | 403 | 0.710 |
Why?
| | Cognitive Dysfunction | 2 | 2022 | 343 | 0.700 |
Why?
| | Head-Down Tilt | 1 | 2020 | 6 | 0.700 |
Why?
| | Diet, High-Fat | 2 | 2021 | 238 | 0.690 |
Why?
| | Animals | 25 | 2024 | 34487 | 0.690 |
Why?
| | Reactive Oxygen Species | 5 | 2024 | 582 | 0.680 |
Why?
| | Doxorubicin | 2 | 2021 | 322 | 0.680 |
Why?
| | Bone Density | 2 | 2021 | 474 | 0.660 |
Why?
| | Antioxidants | 2 | 2023 | 542 | 0.650 |
Why?
| | Prunus domestica | 1 | 2019 | 1 | 0.640 |
Why?
| | Physical Conditioning, Animal | 1 | 2021 | 229 | 0.630 |
Why?
| | Carbon Dioxide | 1 | 2020 | 258 | 0.590 |
Why?
| | Neoplasms | 2 | 2022 | 2460 | 0.580 |
Why?
| | Adipose Tissue, Brown | 1 | 2018 | 51 | 0.580 |
Why?
| | Subcutaneous Fat | 1 | 2018 | 74 | 0.580 |
Why?
| | Cholesterol, LDL | 2 | 2020 | 357 | 0.570 |
Why?
| | Housing, Animal | 1 | 2018 | 47 | 0.570 |
Why?
| | Neovascularization, Pathologic | 1 | 2019 | 289 | 0.560 |
Why?
| | Body Temperature Regulation | 1 | 2018 | 95 | 0.550 |
Why?
| | Weight Loss | 1 | 2022 | 725 | 0.550 |
Why?
| | Colonic Neoplasms | 1 | 2019 | 242 | 0.540 |
Why?
| | Extracellular Matrix | 1 | 2021 | 495 | 0.540 |
Why?
| | Medical Laboratory Science | 1 | 2016 | 9 | 0.540 |
Why?
| | Tumor Necrosis Factor-alpha | 2 | 2021 | 1185 | 0.530 |
Why?
| | Feeding Behavior | 2 | 2019 | 618 | 0.520 |
Why?
| | Physiology | 1 | 2016 | 13 | 0.520 |
Why?
| | Students, Health Occupations | 1 | 2016 | 28 | 0.520 |
Why?
| | Brain | 3 | 2024 | 2615 | 0.500 |
Why?
| | Humans | 41 | 2025 | 128019 | 0.490 |
Why?
| | Bread | 1 | 2015 | 4 | 0.490 |
Why?
| | Cardiovascular System | 1 | 2016 | 136 | 0.480 |
Why?
| | Temperature | 1 | 2018 | 628 | 0.480 |
Why?
| | Breakfast | 1 | 2015 | 15 | 0.480 |
Why?
| | Writing | 1 | 2016 | 91 | 0.480 |
Why?
| | Physical Conditioning, Human | 1 | 2015 | 38 | 0.460 |
Why?
| | Educational Measurement | 1 | 2016 | 257 | 0.440 |
Why?
| | T-Lymphocytes | 1 | 2022 | 1921 | 0.430 |
Why?
| | Blood Pressure | 5 | 2023 | 1711 | 0.430 |
Why?
| | Male | 21 | 2025 | 62757 | 0.410 |
Why?
| | Adipose Tissue | 3 | 2022 | 589 | 0.400 |
Why?
| | Anthracyclines | 2 | 2022 | 46 | 0.400 |
Why?
| | Energy Metabolism | 1 | 2018 | 831 | 0.400 |
Why?
| | Resistance Training | 1 | 2015 | 151 | 0.390 |
Why?
| | Dietary Supplements | 4 | 2023 | 531 | 0.380 |
Why?
| | Carotid Arteries | 2 | 2024 | 194 | 0.360 |
Why?
| | Cholesterol | 3 | 2019 | 406 | 0.360 |
Why?
| | Lipids | 3 | 2020 | 619 | 0.350 |
Why?
| | Randomized Controlled Trials as Topic | 9 | 2023 | 1356 | 0.340 |
Why?
| | Antineoplastic Agents | 1 | 2021 | 2041 | 0.330 |
Why?
| | Bed Rest | 2 | 2020 | 14 | 0.330 |
Why?
| | Clinical Competence | 1 | 2016 | 1007 | 0.320 |
Why?
| | Risk Factors | 6 | 2025 | 9696 | 0.310 |
Why?
| | Muscle, Skeletal | 3 | 2024 | 1619 | 0.280 |
Why?
| | Young Adult | 8 | 2024 | 12281 | 0.280 |
Why?
| | Eating | 3 | 2023 | 368 | 0.260 |
Why?
| | Transcriptome | 2 | 2023 | 879 | 0.260 |
Why?
| | Female | 17 | 2025 | 68016 | 0.250 |
Why?
| | Random Allocation | 2 | 2016 | 342 | 0.240 |
Why?
| | Bottle-Nosed Dolphin | 1 | 2024 | 3 | 0.230 |
Why?
| | Education, Graduate | 1 | 2024 | 35 | 0.230 |
Why?
| | Aged | 9 | 2024 | 21892 | 0.230 |
Why?
| | Apigenin | 1 | 2023 | 3 | 0.220 |
Why?
| | Nitric Oxide | 3 | 2023 | 881 | 0.220 |
Why?
| | Elastic Modulus | 1 | 2024 | 123 | 0.220 |
Why?
| | Synbiotics | 1 | 2023 | 1 | 0.210 |
Why?
| | Peripheral Vascular Diseases | 1 | 2024 | 102 | 0.210 |
Why?
| | Pistacia | 1 | 2023 | 2 | 0.210 |
Why?
| | Goals | 1 | 2024 | 160 | 0.210 |
Why?
| | Vitis | 1 | 2023 | 41 | 0.210 |
Why?
| | Biomarkers | 5 | 2023 | 3874 | 0.200 |
Why?
| | Matrix Metalloproteinase 9 | 1 | 2023 | 112 | 0.200 |
Why?
| | Cardiotoxicity | 1 | 2022 | 33 | 0.200 |
Why?
| | Probiotics | 1 | 2023 | 51 | 0.200 |
Why?
| | Hypertension | 2 | 2023 | 1234 | 0.200 |
Why?
| | Career Choice | 1 | 2024 | 207 | 0.200 |
Why?
| | Age Factors | 3 | 2024 | 3100 | 0.190 |
Why?
| | Antibiotics, Antineoplastic | 1 | 2022 | 120 | 0.190 |
Why?
| | Social Class | 1 | 2024 | 258 | 0.190 |
Why?
| | Femur | 2 | 2021 | 245 | 0.190 |
Why?
| | Frailty | 1 | 2024 | 153 | 0.190 |
Why?
| | Adult | 12 | 2024 | 35176 | 0.190 |
Why?
| | Drinking Water | 1 | 2022 | 74 | 0.180 |
Why?
| | Macular Pigment | 1 | 2021 | 3 | 0.180 |
Why?
| | Methylamines | 1 | 2021 | 27 | 0.180 |
Why?
| | Laboratories | 1 | 2022 | 109 | 0.180 |
Why?
| | Vision, Ocular | 1 | 2021 | 33 | 0.180 |
Why?
| | Sweat | 1 | 2021 | 46 | 0.180 |
Why?
| | Dementia | 1 | 2024 | 227 | 0.180 |
Why?
| | Nitrates | 1 | 2021 | 87 | 0.180 |
Why?
| | Precision Medicine | 1 | 2024 | 384 | 0.170 |
Why?
| | Insulin | 3 | 2019 | 2316 | 0.170 |
Why?
| | Sodium | 1 | 2021 | 202 | 0.170 |
Why?
| | Triglycerides | 3 | 2020 | 523 | 0.170 |
Why?
| | Amino Acids | 2 | 2021 | 476 | 0.170 |
Why?
| | Honey | 1 | 2019 | 8 | 0.170 |
Why?
| | Dietary Sugars | 1 | 2019 | 13 | 0.170 |
Why?
| | Isoflavones | 1 | 2019 | 25 | 0.170 |
Why?
| | Rats, Wistar | 1 | 2021 | 397 | 0.160 |
Why?
| | Vitamins | 1 | 2021 | 174 | 0.160 |
Why?
| | Running | 1 | 2022 | 222 | 0.160 |
Why?
| | Sex Factors | 1 | 2025 | 1942 | 0.160 |
Why?
| | Middle Aged | 9 | 2024 | 30812 | 0.160 |
Why?
| | Adipokines | 1 | 2019 | 47 | 0.150 |
Why?
| | Blood Vessels | 1 | 2020 | 181 | 0.150 |
Why?
| | Collagen | 1 | 2021 | 429 | 0.150 |
Why?
| | Class Ia Phosphatidylinositol 3-Kinase | 1 | 2018 | 7 | 0.150 |
Why?
| | Rats | 3 | 2023 | 5199 | 0.150 |
Why?
| | Postprandial Period | 1 | 2019 | 103 | 0.150 |
Why?
| | Mice, 129 Strain | 1 | 2018 | 79 | 0.150 |
Why?
| | Ceramides | 1 | 2018 | 104 | 0.150 |
Why?
| | Hyperinsulinism | 1 | 2019 | 119 | 0.150 |
Why?
| | Osteogenesis | 1 | 2019 | 175 | 0.140 |
Why?
| | Vitamin D | 1 | 2021 | 380 | 0.140 |
Why?
| | Cholesterol, Dietary | 1 | 2016 | 18 | 0.140 |
Why?
| | Xanthophylls | 1 | 2016 | 18 | 0.140 |
Why?
| | Hot Temperature | 1 | 2019 | 359 | 0.130 |
Why?
| | Polycystic Ovary Syndrome | 1 | 2019 | 163 | 0.130 |
Why?
| | Nutrition Policy | 1 | 2016 | 56 | 0.130 |
Why?
| | Ethanol | 1 | 2021 | 585 | 0.130 |
Why?
| | Body Weight | 4 | 2023 | 930 | 0.130 |
Why?
| | Diabetes Mellitus, Type 2 | 2 | 2021 | 2428 | 0.130 |
Why?
| | Phenotype | 1 | 2024 | 3039 | 0.130 |
Why?
| | Time Factors | 2 | 2018 | 6479 | 0.130 |
Why?
| | Analysis of Variance | 1 | 2019 | 1266 | 0.130 |
Why?
| | Critical Illness | 1 | 2021 | 755 | 0.120 |
Why?
| | Body Composition | 2 | 2020 | 644 | 0.120 |
Why?
| | Hyperglycemia | 1 | 2019 | 326 | 0.120 |
Why?
| | Circadian Rhythm | 1 | 2018 | 409 | 0.120 |
Why?
| | Diabetes Mellitus | 1 | 2023 | 994 | 0.120 |
Why?
| | Gene Expression | 1 | 2019 | 1454 | 0.110 |
Why?
| | Overweight | 1 | 2019 | 522 | 0.110 |
Why?
| | Liver | 1 | 2023 | 1826 | 0.110 |
Why?
| | Mitochondria | 1 | 2020 | 847 | 0.110 |
Why?
| | Adiposity | 1 | 2019 | 504 | 0.110 |
Why?
| | Energy Intake | 3 | 2020 | 454 | 0.100 |
Why?
| | Cognition | 1 | 2020 | 1104 | 0.100 |
Why?
| | Adolescent | 3 | 2022 | 20158 | 0.100 |
Why?
| | Disease Models, Animal | 2 | 2019 | 3936 | 0.090 |
Why?
| | Mice, Knockout | 1 | 2018 | 2757 | 0.090 |
Why?
| | Cytokines | 1 | 2019 | 1984 | 0.090 |
Why?
| | Chickens | 2 | 2021 | 187 | 0.080 |
Why?
| | Cholesterol, HDL | 2 | 2020 | 203 | 0.080 |
Why?
| | Chronic Disease | 1 | 2015 | 1690 | 0.080 |
Why?
| | Heart Rate | 2 | 2023 | 797 | 0.070 |
Why?
| | Cross-Over Studies | 2 | 2021 | 507 | 0.070 |
Why?
| | Healthy Aging | 1 | 2024 | 34 | 0.060 |
Why?
| | Surveys and Questionnaires | 1 | 2016 | 5353 | 0.060 |
Why?
| | Nuts | 1 | 2023 | 10 | 0.050 |
Why?
| | Butanols | 1 | 2022 | 8 | 0.050 |
Why?
| | Child | 1 | 2022 | 20636 | 0.050 |
Why?
| | Models, Animal | 1 | 2024 | 365 | 0.050 |
Why?
| | Vasodilator Agents | 1 | 2024 | 323 | 0.050 |
Why?
| | Superoxides | 1 | 2022 | 196 | 0.050 |
Why?
| | Body Mass Index | 2 | 2020 | 2260 | 0.050 |
Why?
| | Lutein | 1 | 2021 | 14 | 0.050 |
Why?
| | Zeaxanthins | 1 | 2021 | 16 | 0.050 |
Why?
| | Sweating | 1 | 2021 | 40 | 0.040 |
Why?
| | Estrogens | 1 | 2023 | 342 | 0.040 |
Why?
| | Social Determinants of Health | 1 | 2024 | 220 | 0.040 |
Why?
| | Observational Studies as Topic | 1 | 2021 | 108 | 0.040 |
Why?
| | Rats, Zucker | 1 | 2019 | 30 | 0.040 |
Why?
| | Diet, Carbohydrate-Restricted | 1 | 2020 | 32 | 0.040 |
Why?
| | Phytoestrogens | 1 | 2019 | 17 | 0.040 |
Why?
| | Fibroblast Growth Factors | 1 | 2021 | 170 | 0.040 |
Why?
| | Osteocalcin | 1 | 2019 | 36 | 0.040 |
Why?
| | Diet, Fat-Restricted | 1 | 2020 | 80 | 0.040 |
Why?
| | United States | 1 | 2016 | 13785 | 0.040 |
Why?
| | Dietary Sucrose | 1 | 2019 | 48 | 0.040 |
Why?
| | Enteral Nutrition | 1 | 2021 | 186 | 0.040 |
Why?
| | Immersion | 1 | 2019 | 6 | 0.040 |
Why?
| | Anthropometry | 1 | 2020 | 204 | 0.040 |
Why?
| | Oxygen Consumption | 1 | 2022 | 669 | 0.040 |
Why?
| | Exercise Test | 1 | 2022 | 613 | 0.040 |
Why?
| | Glucose Tolerance Test | 1 | 2019 | 356 | 0.040 |
Why?
| | Rats, Sprague-Dawley | 1 | 2023 | 2258 | 0.040 |
Why?
| | C-Reactive Protein | 1 | 2019 | 396 | 0.030 |
Why?
| | Respiration, Artificial | 1 | 2021 | 600 | 0.030 |
Why?
| | Bone and Bones | 1 | 2019 | 298 | 0.030 |
Why?
| | Osteoporosis | 1 | 2019 | 233 | 0.030 |
Why?
| | Critical Care | 1 | 2021 | 550 | 0.030 |
Why?
| | Intensive Care Units | 1 | 2021 | 734 | 0.030 |
Why?
| | Length of Stay | 1 | 2021 | 1114 | 0.030 |
Why?
| | Interleukin-6 | 1 | 2019 | 712 | 0.030 |
Why?
|
|
Clayton's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|